377 related articles for article (PubMed ID: 32616754)
1. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
3. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
4. Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer.
Morla-Barcelo PM; Laguna-Macarrilla D; Cordoba O; Matheu G; Oliver J; Roca P; Nadal-Serrano M; Sastre-Serra J
Breast Cancer Res; 2024 Jun; 26(1):89. PubMed ID: 38831458
[TBL] [Abstract][Full Text] [Related]
5. Identifying the mRNAs associated with Bladder cancer recurrence.
Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
[TBL] [Abstract][Full Text] [Related]
6. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
8. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y
Hereditas; 2019; 156():20. PubMed ID: 31285741
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
10. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
[TBL] [Abstract][Full Text] [Related]
11. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Yang L; Jing J; Sun L; Yue Y
Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hub Genes as Biomarkers Correlated with the Proliferation and Prognosis in Lung Cancer: A Weighted Gene Co-Expression Network Analysis.
Xu X; Xu L; Huang H; Li J; Dong S; Jin L; Ma Z; Li L
Biomed Res Int; 2020; 2020():3416807. PubMed ID: 32596300
[TBL] [Abstract][Full Text] [Related]
17. Screening and identification of key biomarkers in alimentary tract cancers: A bioinformatic analysis.
Cai Z; Wei Y; Chen S; Gong Y; Fu Y; Dai X; Zhou Y; Yang H; Tang L; Liu H
Cancer Biomark; 2020; 29(2):221-233. PubMed ID: 32623389
[TBL] [Abstract][Full Text] [Related]
18. Microarray Analysis for Differentially Expressed Genes Between Stromal and Epithelial Cells in Development and Metastasis of Invasive Breast Cancer.
Wang R; Fu L; Li J; Zhao D; Zhao Y; Yin L
J Comput Biol; 2020 Dec; 27(12):1631-1643. PubMed ID: 32429691
[TBL] [Abstract][Full Text] [Related]
19. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
20. In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers.
Kim J
World J Surg Oncol; 2021 Jun; 19(1):188. PubMed ID: 34172056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]